Vaccines
Vaccines
Evaluate vaccine candidates with immunogenicity assays, comprehensive cytokine profiling, adjuvant characterization tools, and immune response monitoring platforms.
Supporting the Vaccine Development Lifecycle
Vaccine development demands rigorous characterization of immune responses from early antigen selection through clinical immunogenicity evaluation. Enzo Life Sciences provides essential tools for vaccine researchers — including cytokine and chemokine profiling panels for measuring innate and adaptive immune activation, adjuvant research reagents, and comprehensive immunological readouts that support regulatory submissions from preclinical through Phase III development.
Immunogenicity Assessment
Antibody titer quantification, seroconversion assays, and neutralization readouts for evaluating vaccine-induced humoral immunity. ELISA platforms with species-specific secondary antibodies and isotype profiling for comprehensive serological analysis.
Cytokine Profiling
Multiplex cytokine and chemokine panels for measuring Th1/Th2 polarization, innate immune activation, and inflammatory responses to vaccine candidates. Quantify IL-2, IL-4, IL-6, IL-10, IFN-γ, TNF-α, and additional cytokines from serum and culture supernatants.
Adjuvant Research
Innate immune activation assays and pattern recognition receptor tools for adjuvant characterization and optimization. TLR agonist detection, NF-κB reporter assays, and inflammasome activation platforms for understanding adjuvant mechanisms of action.
Cellular Immunity
T-cell activation and proliferation assays, intracellular cytokine staining reagents, and cell-mediated immunity readouts. Support evaluation of vaccine-induced cellular immune responses critical for protection against intracellular pathogens and cancer.
Vaccines — By the Numbers
Support Your Vaccine Program
Explore our curated product selection or contact our scientific support team for personalized recommendations.